(19)
(11) EP 4 680 213 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24706123.7

(22) Date of filing: 21.02.2024
(51) International Patent Classification (IPC): 
A61K 31/015(2006.01)
A61K 31/202(2006.01)
A61P 29/00(2006.01)
A23L 33/00(2016.01)
 A61K 31/045(2006.01)
A61P 25/04(2006.01)
A61P 39/06(2006.01)
A61K 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/015; A61K 31/202; A61K 31/045; A61P 25/04; A61P 29/00; A61P 39/06; A23L 33/10; A23L 33/115; A23L 33/105; A61K 9/48; A61K 9/50; A61K 36/61
 
C-Sets:
  1. A61K 31/015, A61K 2300/00;
  2. A61K 31/202, A61K 2300/00;
  3. A61K 31/045, A61K 2300/00;
(86) International application number:
PCT/EP2024/054371
(87) International publication number:
WO 2024/188608 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 16.03.2023 IT 202300004953

(71) Applicant: Targeting Gut Disease S.r.l.
40127 Bologna, BO (IT)

(72) Inventor:
  • VALERII, Maria Chiara
    40127 Bologna BO (IT)

(74) Representative: Longoni, Alessandra et al
Fumero S.r.l. AL & Partners Department Via C. Colombo angolo Via Appiani
20831 Seregno (MB)
20831 Seregno (MB) (IT)

   


(54) COMPOSITION CONTAINING BETA-CARYOPHYLLENE, DOCOSAHEXAENOIC ACID AND EUGENOL FOR USE AS ANALGESIC AND ANTI-INFLAMMATORY ANTIOXIDANT FOR THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM